Speakers

Expand/Collapse

Arpan Desai
Managing Director
NanoVation Therapeutics

Day One

Wednesday 19th October 2022

8:30 am | Panel Discussion: Setting the Context – Current & Potential Uses of LNPs

Ben Knappett
Head of Science & Applications
Particle Works

Day One

Wednesday 19th October 2022

4:30 pm | Automated High-Throughput Screening of LNP Formulations

Edward Grahame
Field Application Scientist
Precision NanoSystems

Lu Tian
Director, CMC Project Management
STA Pharmaceutical

Day Two

Thursday 20th October 2022

11:30 am | Outlining Oligo Drug Delivery & LNP Platform at WuXi STA

Senior Representative

Knauer

Day Two

Thursday 20th October 2022

12:30 pm | Session Reserved for Knauer

Mostafa Nakach
Head of Formulation & Process Development
Sanofi

Day Two

Thursday 20th October 2022

2:15 pm | Scale Up of Nano-Drug Delivery Systems Manufacturing for Clinical Investigations

1:45 pm | Panel Discussion: Review the Challenges of Effectively Scaling LNPs

Shahid Uddin
Senior Director of Formulation & Stability
Mendus

Day Two

Thursday 20th October 2022

4:15 pm | Chair’s Closing Remarks & End of Summit

8:20 am | Chair’s Opening Remarks

Shashank Pinnapireddy
Head of Nanoparticle Research
CSL Behring

Day One

Wednesday 19th October 2022

8:30 am | Panel Discussion: Setting the Context – Current & Potential Uses of LNPs

Day Two

Thursday 20th October 2022

9:00 am | Roundtable Discussion: LNP Stability & Storage – Overcoming the Barriers

Sune Andersen
Principal Scientist in Particle Engineering
Janssen

Day Two

Thursday 20th October 2022

8:30 am | Advancing Methods to Address the Stability Challenge

Juliana Haggerty
Head of Center of Excellence – LNP
CPI

Day Two

Thursday 20th October 2022

1:45 pm | Panel Discussion: Review the Challenges of Effectively Scaling LNPs

12:00 pm | Accelerating Scale Up & GMP Manufacturing of LNPs

Dimitrios A. Lamprou
Professor (Chair) of Biofabrication and Advanced Manufacturing
Queen's University Belfast

Day Two

Thursday 20th October 2022

3:45 pm | Continuous & Scalable Manufacturing of LNPs by Microfluidics

Geoffrey Prevot
Formulation Project Manager
Servier

Day One

Wednesday 19th October 2022

4:45 pm | Delivering RNA to Neutrons In Vitro & In Vivo

1:45 pm | Panel Discussion: To the Liver & Beyond – Exploring Novel Delivery Areas

Sanyogitta Puri
Director
AstraZeneca

Day One

Wednesday 19th October 2022

5:15 pm | Chair’s Closing Remarks & End of Day One

8:20 am | Chair’s Opening Remarks

Day Two

Thursday 20th October 2022

9:45 am | Fireside Chat: Accelerating LNP Products into the Clinic - Beyond Vaccines

Zohreh Amoozgar
Principal Scientist
Sanofi

Day Two

Thursday 20th October 2022

9:45 am | Fireside Chat: Accelerating LNP Products into the Clinic - Beyond Vaccines

Pierre-Alexandre Driguez
Head of mRNA Platform - Vitry
Sanofi

Day One

Wednesday 19th October 2022

1:45 pm | Panel Discussion: To the Liver & Beyond – Exploring Novel Delivery Areas

Daniel L. Shores
Partner
Rothwell Figg

Day One

Wednesday 19th October 2022

11:45 am | Virtual Navigating the IP Landscape for LNP Delivery Technology

Driton Vllasaliu
Senior Lecturer in Pharmaceutics
Kings College London

Day One

Wednesday 19th October 2022

9:30 am | Alternative Systems for Mucosal Delivery of Nucleic Acids

Kristina Friis
Senior Scientist, Advanced Drug Delivery
AstraZeneca

Day One

Wednesday 19th October 2022

2:45 pm | Spray Drying of LNPs Enables Intratracheal Delivery of mRNA

8:30 am | Panel Discussion: Setting the Context – Current & Potential Uses of LNPs

Rob Worsham
Senior Director, Manufacturing Science & Technology
Insmed

Day Two

Thursday 20th October 2022

3:15 pm | Optimisation of Continuous Manufacturing for Liposomal Drug Products

Stephen Lock
Senior Market Development Manager
Biopharma EMEAI, SCIEX

Moein Moghimi
Professor
University of Newcastle

Day One

Wednesday 19th October 2022

9:00 am | Pro-Inflammatory Concerns Associated with LNPs

Ken Howard
Associate Professor
Aarhus University

Day One

Wednesday 19th October 2022

11:15 am | Biomolecular Oligonucleotide Assembles for Systemic Delivery of Therapeutic Nucleic Acids

10:00 am | Biomolecular Oligonucleotide Assembles for Systemic Delivery of Therapeutic Nucleic Acids

Nawel Khalef
Associate Professor
University of Joseph Fourier, Grenoble

Dai Hayward
CEO
Micropore Technologies Ltd.

Day One

Wednesday 19th October 2022

3:15 pm | Compliant Scalability of LNP Manufacture from Lab to 1 Billion Dose

Zongyi Li
Post-Doctoral Researcher
University of Manchester

Day One

Wednesday 19th October 2022

4:00 pm | Utilising Small-Angle Neutron Scattering (SANS) to Understand the Structure of LNPs

8:30 am | Panel Discussion: Setting the Context – Current & Potential Uses of LNPs

Nikolas N. Daskalakis
Senior Scientist, Advanced Drug Delivery
AstraZeneca

Edward Grahame
Field Application Scientist
Precision Nanosystems

Day One

Wednesday 19th October 2022

12:15 pm | GenVoy™ Lipid Nanoparticles: A Versatile Tool for Developing RNA Vaccines

Day Two

Thursday 20th October 2022

1:45 pm | Panel Discussion: Review the Challenges of Effectively Scaling LNPs